GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,452,000 | -1.7% | 194,167 | -1.6% | 0.92% | +21.6% |
| Q1 2022 | $8,597,000 | -1.8% | 197,364 | -0.6% | 0.76% | -4.9% |
| Q4 2021 | $8,754,000 | +14.5% | 198,499 | -0.8% | 0.80% | +4.3% |
| Q3 2021 | $7,643,000 | -6.6% | 200,023 | -2.7% | 0.77% | -2.3% |
| Q2 2021 | $8,185,000 | +10.5% | 205,560 | -1.0% | 0.78% | +9.2% |
| Q1 2021 | $7,409,000 | +6.5% | 207,587 | +9.9% | 0.72% | -0.7% |
| Q4 2020 | $6,954,000 | +4.6% | 188,973 | +7.0% | 0.72% | +10.2% |
| Q3 2020 | $6,646,000 | -10.7% | 176,563 | -3.2% | 0.66% | -15.9% |
| Q2 2020 | $7,442,000 | +2.4% | 182,453 | -4.8% | 0.78% | -10.8% |
| Q1 2020 | $7,265,000 | -11.8% | 191,743 | +9.4% | 0.88% | +18.1% |
| Q4 2019 | $8,238,000 | +8.6% | 175,313 | -1.4% | 0.74% | +5.4% |
| Q3 2019 | $7,587,000 | +6.5% | 177,770 | -0.1% | 0.70% | +55.1% |
| Q2 2019 | $7,124,000 | -9.5% | 178,005 | -5.5% | 0.45% | -39.8% |
| Q1 2019 | $7,870,000 | -13.8% | 188,325 | -21.2% | 0.75% | +7.4% |
| Q4 2018 | $9,131,000 | -8.1% | 238,970 | -3.3% | 0.70% | -15.1% |
| Q3 2018 | $9,932,000 | -12.1% | 247,250 | -11.8% | 0.83% | +0.4% |
| Q2 2018 | $11,294,000 | +1.9% | 280,185 | -1.2% | 0.82% | -7.2% |
| Q1 2018 | $11,078,000 | +13.7% | 283,555 | +3.2% | 0.89% | +31.6% |
| Q4 2017 | $9,744,000 | +13.0% | 274,720 | +29.4% | 0.68% | +0.9% |
| Q3 2017 | $8,622,000 | +71.0% | 212,360 | +81.6% | 0.67% | +53.8% |
| Q2 2017 | $5,043,000 | -1.0% | 116,960 | -3.2% | 0.44% | -5.2% |
| Q1 2017 | $5,095,000 | +11.3% | 120,845 | +1.7% | 0.46% | -8.0% |
| Q4 2016 | $4,577,000 | -21.2% | 118,855 | -11.8% | 0.50% | -41.6% |
| Q3 2016 | $5,809,000 | +11.6% | 134,681 | +12.1% | 0.85% | -1.2% |
| Q2 2016 | $5,206,000 | +18.8% | 120,116 | +11.1% | 0.86% | +16.8% |
| Q1 2016 | $4,382,000 | +3.7% | 108,075 | +3.2% | 0.74% | -13.8% |
| Q4 2015 | $4,226,000 | -37.5% | 104,740 | -40.4% | 0.86% | -34.3% |
| Q3 2015 | $6,760,000 | +147.1% | 175,805 | +167.6% | 1.31% | +287.5% |
| Q2 2015 | $2,736,000 | -30.4% | 65,700 | -22.9% | 0.34% | -39.9% |
| Q1 2015 | $3,931,000 | +6.4% | 85,185 | -1.4% | 0.56% | +53.7% |
| Q4 2014 | $3,693,000 | -1.4% | 86,395 | +6.0% | 0.36% | +0.3% |
| Q3 2014 | $3,747,000 | -12.1% | 81,520 | +2.3% | 0.36% | -6.4% |
| Q2 2014 | $4,264,000 | +13.3% | 79,725 | +13.1% | 0.39% | +9.9% |
| Q1 2014 | $3,765,000 | +10.0% | 70,460 | +9.9% | 0.35% | +13.8% |
| Q4 2013 | $3,423,000 | -6.1% | 64,105 | -11.8% | 0.31% | -31.6% |
| Q3 2013 | $3,647,000 | -7.9% | 72,700 | -8.3% | 0.46% | +4955.6% |
| Q2 2013 | $3,960,000 | – | 79,245 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |